Leading the Way in Life Science Technologies

GEN Exclusives

More »

Companies

More »

Updated: Jul 2 2012

WaferGen Biosystems

  • WaferGen Biosystems
  • 7400 Paseo Padre Parkway
  • Fremont, CA, 94555
  • UNITED STATES

Increasing interest in personalized medicine has led to the need for accurate, highly sensitive, high-throughput gene expression data by researchers, clinicians and pharmaceutical companies. WaferGen is addressing that need with the SmartChip System. It is the first system to combine the high-throughput capability and cost efficiencies of microarrays, with the sensitivity and accuracy of real-time PCR, enabling researchers to advance from biomarker discovery to target validation on a single integrated platform.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »